ADHD in adolescents: no demonstrated additional benefit from Goal Management Training

Training executive functions may seem like a logical way to help adolescents with ADHD. But in a multicenter randomized trial involving 116 participants, adding Goal Management Training to usual care provided no demonstrated additional benefit at 12 weeks. This finding concerns this specific program, not all non-drug interventions.

Illustration of a group goal management session for adolescents.
MindsetEditorial illustration, not study data.

A program added to usual care

The researchers compared two groups of adolescents with attention-deficit/hyperactivity disorder. One received usual care, while the other received the same care supplemented with Goal Management Training, or GMT. The mean age was 14.69 years, and 66% of participants were female.

GMT consisted of seven weekly two-hour group sessions, supplemented by sessions for parents and teachers. Usual care consisted of standard outpatient mental health services.

The trial was preregistered. Assessments took place at baseline and after 12 weeks. The primary outcome was a global executive function score, measured using the parent-completed BRIEF-2 questionnaire.

No advantage detected on the outcomes assessed

The intention-to-treat analysis showed no statistically significant difference between the groups on the primary outcome. The adjusted difference was −2.12, with a 95% confidence interval ranging from −7.64 to 3.41. This interval includes no difference.

The researchers also detected no additional benefit for parent-reported ADHD symptoms or other secondary outcomes. These included executive function assessments from multiple informants, symptoms and functional impairment.

The comparison specifically concerns adding GMT to usual care. It does not establish that usual care is ineffective or that participants experienced no improvement.

A limit to the promise, not a universal verdict

For a family considering this program, this trial provides no evidence of an additional advantage at 12 weeks. A structured intervention targeting executive functions therefore does not, by itself, guarantee measurable improvement.

However, the absence of a statistically significant difference does not demonstrate perfect equivalence between the two care approaches. The abstract provided also does not allow assessment of effects beyond 12 weeks, tolerability or possible reasons for this result.

Limitations to keep in mind

Only the PubMed abstract was consulted, not the full text. The results concern an assessment at 12 weeks. The abstract does not detail adverse effects, funding or conflicts of interest, which remain unverified.

What we can take away

GMT added to usual care showed no additional benefit in this trial involving adolescents with ADHD. This finding calls for more measured expectations of this program, without generalizing to all non-drug approaches.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.